ABSCI CORP (ABSI) Fundamental Analysis & Valuation

NASDAQ:ABSI • US00091E1091

Current stock price

3.94 USD
-0.03 (-0.76%)
At close:
3.9148 USD
-0.03 (-0.64%)
After Hours:

This ABSI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ABSI Profitability Analysis

1.1 Basic Checks

  • In the past year ABSI has reported negative net income.
  • ABSI had a negative operating cash flow in the past year.
  • ABSI had negative earnings in each of the past 5 years.
  • In the past 5 years ABSI always reported negative operating cash flow.
ABSI Yearly Net Income VS EBIT VS OCF VS FCFABSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • ABSI's Return On Assets of -53.25% is in line compared to the rest of the industry. ABSI outperforms 44.57% of its industry peers.
  • ABSI has a Return On Equity of -60.80%. This is comparable to the rest of the industry: ABSI outperforms 56.40% of its industry peers.
Industry RankSector Rank
ROA -53.25%
ROE -60.8%
ROIC N/A
ROA(3y)-50.8%
ROA(5y)-41.86%
ROE(3y)-60.37%
ROE(5y)-49.51%
ROIC(3y)N/A
ROIC(5y)N/A
ABSI Yearly ROA, ROE, ROICABSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

1.3 Margins

  • ABSI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABSI Yearly Profit, Operating, Gross MarginsABSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K -4K

8

2. ABSI Health Analysis

2.1 Basic Checks

  • ABSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ABSI has more shares outstanding
  • The number of shares outstanding for ABSI has been increased compared to 5 years ago.
  • ABSI has a better debt/assets ratio than last year.
ABSI Yearly Shares OutstandingABSI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ABSI Yearly Total Debt VS Total AssetsABSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • ABSI has an Altman-Z score of 8.23. This indicates that ABSI is financially healthy and has little risk of bankruptcy at the moment.
  • ABSI's Altman-Z score of 8.23 is fine compared to the rest of the industry. ABSI outperforms 78.68% of its industry peers.
  • There is no outstanding debt for ABSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.23
ROIC/WACCN/A
WACC9.41%
ABSI Yearly LT Debt VS Equity VS FCFABSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 6.57 indicates that ABSI has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 6.57, ABSI is doing good in the industry, outperforming 64.92% of the companies in the same industry.
  • ABSI has a Quick Ratio of 6.57. This indicates that ABSI is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ABSI (6.57) is better than 65.31% of its industry peers.
Industry RankSector Rank
Current Ratio 6.57
Quick Ratio 6.57
ABSI Yearly Current Assets VS Current LiabilitesABSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

4

3. ABSI Growth Analysis

3.1 Past

  • ABSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.60%, which is quite good.
  • ABSI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.24%.
  • The Revenue for ABSI have been decreasing by -10.14% on average. This is quite bad
EPS 1Y (TTM)8.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)-38.24%
Revenue growth 3Y-21.33%
Revenue growth 5Y-10.14%
Sales Q2Q%-2.26%

3.2 Future

  • ABSI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.60% yearly.
  • The Revenue is expected to grow by 92.38% on average over the next years. This is a very strong growth
EPS Next Y1.26%
EPS Next 2Y11.43%
EPS Next 3Y11.71%
EPS Next 5Y13.6%
Revenue Next Year76.24%
Revenue Next 2Y171.77%
Revenue Next 3Y130.02%
Revenue Next 5Y92.38%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABSI Yearly Revenue VS EstimatesABSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
ABSI Yearly EPS VS EstimatesABSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -0.5 -1 -1.5 -2

0

4. ABSI Valuation Analysis

4.1 Price/Earnings Ratio

  • ABSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ABSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABSI Price Earnings VS Forward Price EarningsABSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABSI Per share dataABSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.43%
EPS Next 3Y11.71%

0

5. ABSI Dividend Analysis

5.1 Amount

  • No dividends for ABSI!.
Industry RankSector Rank
Dividend Yield 0%

ABSI Fundamentals: All Metrics, Ratios and Statistics

ABSCI CORP

NASDAQ:ABSI (4/24/2026, 8:19:53 PM)

After market: 3.9148 -0.03 (-0.64%)

3.94

-0.03 (-0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-24
Earnings (Next)05-07
Inst Owners76.34%
Inst Owner Change0.13%
Ins Owners6.57%
Ins Owner Change3.12%
Market Cap602.90M
Revenue(TTM)2.80M
Net Income(TTM)-115.18M
Analysts81.33
Price Target8.19 (107.87%)
Short Float %28.22%
Short Ratio10.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.22%
Min EPS beat(2)-0.92%
Max EPS beat(2)7.37%
EPS beat(4)2
Avg EPS beat(4)1.49%
Min EPS beat(4)-10.99%
Max EPS beat(4)10.49%
EPS beat(8)2
Avg EPS beat(8)-2.78%
EPS beat(12)2
Avg EPS beat(12)-9.53%
EPS beat(16)3
Avg EPS beat(16)-7.41%
Revenue beat(2)0
Avg Revenue beat(2)-59.76%
Min Revenue beat(2)-77.45%
Max Revenue beat(2)-42.07%
Revenue beat(4)0
Avg Revenue beat(4)-46.57%
Min Revenue beat(4)-77.45%
Max Revenue beat(4)-12.08%
Revenue beat(8)0
Avg Revenue beat(8)-43.41%
Revenue beat(12)1
Avg Revenue beat(12)-41.72%
Revenue beat(16)2
Avg Revenue beat(16)-40.25%
PT rev (1m)-0.21%
PT rev (3m)-0.21%
EPS NQ rev (1m)-16.67%
EPS NQ rev (3m)-16.67%
EPS NY rev (1m)-17.79%
EPS NY rev (3m)-17.79%
Revenue NQ rev (1m)-24.94%
Revenue NQ rev (3m)-24.94%
Revenue NY rev (1m)-57.34%
Revenue NY rev (3m)-57.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 215.32
P/FCF N/A
P/OCF N/A
P/B 3.18
P/tB 4.08
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.84
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS0.02
BVpS1.24
TBVpS0.97
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -53.25%
ROE -60.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.8%
ROA(5y)-41.86%
ROE(3y)-60.37%
ROE(5y)-49.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.43%
Cap/Sales 39.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.57
Quick Ratio 6.57
Altman-Z 8.23
F-Score3
WACC9.41%
ROIC/WACCN/A
Cap/Depr(3y)6.2%
Cap/Depr(5y)142.97%
Cap/Sales(3y)21.16%
Cap/Sales(5y)228.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y1.26%
EPS Next 2Y11.43%
EPS Next 3Y11.71%
EPS Next 5Y13.6%
Revenue 1Y (TTM)-38.24%
Revenue growth 3Y-21.33%
Revenue growth 5Y-10.14%
Sales Q2Q%-2.26%
Revenue Next Year76.24%
Revenue Next 2Y171.77%
Revenue Next 3Y130.02%
Revenue Next 5Y92.38%
EBIT growth 1Y-16.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.36%
EBIT Next 3Y3.74%
EBIT Next 5Y-0.65%
FCF growth 1Y-29.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.35%
OCF growth 3YN/A
OCF growth 5YN/A

ABSCI CORP / ABSI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ABSCI CORP (ABSI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ABSI.


What is the valuation status of ABSCI CORP (ABSI) stock?

ChartMill assigns a valuation rating of 0 / 10 to ABSCI CORP (ABSI). This can be considered as Overvalued.


Can you provide the profitability details for ABSCI CORP?

ABSCI CORP (ABSI) has a profitability rating of 1 / 10.